FMP

FMP

Enter

ACHV - Achieve Life Science...

photo-url-https://images.financialmodelingprep.com/symbol/ACHV.png

Achieve Life Sciences, Inc.

ACHV

NASDAQ

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

3.69 USD

-0.13 (-3.52%)

About

ceo

Dr. Richard A. B. Stewart

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

CIK

0000949858

ISIN

US0044685008

CUSIP

004468203

Address

1040 West Georgia Street

Phone

14256861500

Country

CA

Employee

22

IPO Date

Oct 12, 1995

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep